Pan-cancer and CRC-specific association indicated that claudin-7 is a tumor suppressor via modulating proliferation, migration, immune microenvironment, and drug sensitivity
Year: 2026
Type: article
Abstract: : Claudin-7, a crucial tight junction protein, governs cell adhesion and permeability, yet its aberrant regulation is a common feature across numerous cancers. Despite this widespread implication, the intricate and context-dependent roles of claudin-7 in different malignancies have remained shrouded in mystery, with existing studies often confining their scope to singular tumor types. This study presents an integrated pan-cancer analysis, meticulously dissecting claudin-7 expression landscapes, prognostic signatures, immune-modulatory prowess, and interactions with therapeutic modalities. In this investigation, we uncover distinct expression profiles of claudin-7 across cancers. Claudin-7 expression is implicated in shaping the tumor immune microenvironment, with its levels correlating with the presence and abundance of various tumor-infiltrating immune cells. Downregulation of claudin-7 in colorectal cancer promotes proliferation and migration. Its downregulation promoted cell EMT and metastasis via upregulating ZEB1. Knockout of claudin-7 also modulates EGFR and several immune signaling pathways. Drug sensitivity analysis suggests that claudin-7 modulates tumor growth through drug sensitivity in colorectal cancer. Our findings underscore the multifaceted significance of claudin-7 in cancer, emphasizing its compelling potential as both a therapeutic target and a biomarker across various cancer types. Together, these revelations illuminate claudin-7's as a sentinel against tumor progression, brandishing its potential as both a linchpin therapeutic target and a potential biomarker.
Source: Genes & Diseases
Authors: Jichuan Quan, Jianwei Liang, Xishan Wang, Jian Peng
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: claudin-7, tumor suppressor, pan-cancer analysis, colorectal cancer, tight junction proteins, tumor immune microenvironment, tumor-infiltrating immune cells, cell proliferation, cell migration, epithelial-mesenchymal transition, ZEB1, EGFR signaling, drug sensitivity, therapeutic target, biomarkers
Open Access status: gold
Estimated APC paid: $2,500
Awards: G2453992762, G3182754738
OpenAlex ID: W7203896166
